The National Institute for Innovation of Manufacturing Biopharmaceuticals was announced by U.S. Secretary of Commerce Penny Pritzker this month. The institute will be operated by more than 150 companies, nonprofits, educational institutions and state governments. This will include two Maryland universities –  The University of Maryland, College Park and University of Maryland, Baltimore. The project includes a $250 million investment, $70 million of which is a federal investment.

The goal of the institute will be to bring safe biopharmaceutical products to market faster and to develop workforce training. As Governor Larry Hogan said,

“The University System of Maryland is a tremendous asset in preparing our workforce for the jobs of the future and leading groundbreaking research. This cutting-edge institute will bring together innovators from private industry, higher education, and government to tackle some of the world’s most pressing medical challenges, such as treating cancer and Alzheimer’s, and will advance the biomanufacturing sector in Maryland and across the nation.”